Danish medical device maker Coloplast is said to have paid $16 million to settle lawsuits claiming it injured women with vaginal-mesh inserts. With settlement talk swirling around at least 5 more makers of the plagued devices, that has some watchers saying the time may be ripe for a global settlement.
Medtronic has revealed details about the mounting legal troubles it faces concerning its Infuse bone growth spinal implant. About 700 lawsuits involving 1,000 personal injury cases are now pending over the controversial product, according to a recent regulatory filing.
A critical FDA panel meeting for Staar Surgical Company's new lens implant product, snowed out by a fierce winter storm last month, has been set for Friday, March 14, the company said in its fourth-quarter earnings report.
Medtronic said it has implanted its new supersmall leadless pacemaker in its first U.S. patient as part of a global clinical trial of the device. This comes a few weeks after rival St. Jude Medical hit the same milestone with its own competing product.
Medtronic scored both a CE mark and FDA 510(k) clearance for a super-small wireless cardiac monitoring device-implant, and the Minnesota device giant is now pursuing a global rollout.
Global fallout from the Poly Implant Prothèse breast implant scandal continues, as the Welsh government refused to pay £1.2 million to replace faulty implants in women.
Amedica has priced its public offering, and in doing so has lowered expectations for the second time this week. The Utah medical device company said it will roll out of the gate with an offering of 3.5 million shares of common stock at $5.75 per share, a price much lower than the company initially proposed.
Already a must-have in med tech research labs, 3-D printing has been sweeping into medical practice. Now it's in a cancer patient's hip.
It's a story that could confirm the worst fears of med tech implant wearers at the highest level of U.S. government: Some time during the first half of 2013, hackers reportedly broke into the computer networks of the big three medical device makers, and the breach might have stayed open for "several months."
Medtronic has failed to prevent another lawsuit involving its Infuse bone growth spinal implant from advancing. It's an ominous sign as the Minnesota device giant gears up for a growing number of related cases that are working their way through the court system.